Press release
Antisense And RNAi Therapeutics Market 2022 Latest Insights, Growth Rate, Future Trends And Forecast | Key Players : Alnylam Pharmaceuticals, Benitec Biopharma Ltd., Gene Signal, GlaxoSmithKline Plc
Antisense & RNAi Therapeutics Market
The Business Research Company offers the Antisense And RNAi Therapeutics Global Market Report 2022 in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market's historic and forecast growth, and highlights important trends and strategies that players in the market can adopt.
Directly purchase the report here: https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3389
The antisense & RNAi therapeutics market consists of sales of antisense & RNAi therapeutics products and related services by entities (organizations, sole traders and partnerships) that develop antisense & RNAi therapeutics to treat various diseases. RNA interference (RNAi)-based and RNA-based antisense oligonucleotide therapies are advanced methods used for the treatment of various respiratory diseases including chronic obstructive pulmonary disease (COPD) and asthma. In addition to this, antisense & RNAi therapeutics finds its application in curing cancer, infectious diseases, cardiovascular diseases, and genetic disorders.
Some key players antisense & RNAi therapeutics market are Alnylam Pharmaceuticals, Benitec Biopharma Ltd., Gene Signal, GlaxoSmithKline Plc, Ionis Pharmaceuticals, Marina Biosciences, Quark Pharmaceuticals, Sanofi S.A, Acuitas Therapeutics and Antisense Therapeutics Ltd.
The countries covered in the global antisense and rnai therapeutics market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.
The regions covered in the global antisense and rnai therapeutics market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Antisense And RNAi Therapeutics Market Segmentation:
1) By Technology
RNA Interference
Antisense RNA
2) By Route of Administration
Pulmonary Delivery
Intravenous Injections
Intra-Dermal Injections
Intraperitoneal Injections
Topical Delivery
Other Delivery Methods
3) By Indication
Oncology
Cardiovascular Diseases (CVDs)
Respiratory Disorders
See more on the report at https://www.thebusinessresearchcompany.com/report/antisense-and-rnai-therapeutics-global-market-report
The Report's Table Of Contents includes
1. Executive Summary
2. Antisense & RNAi Therapeutics Market Characteristics
3. Antisense & RNAi Therapeutics Market Trends And Strategies
4. Impact Of COVID-19 On Antisense & RNAi Therapeutics
5. Antisense & RNAi Therapeutics Market Size And Growth
……
28. Antisense & RNAi Therapeutics Pipeline Analysis
29. Key Mergers And Acquisitions In The Antisense & RNAi Therapeutics Market
30. Antisense & RNAi Therapeutics Market Future Outlook and Potential Analysis
31. Appendix
This report covers the trends and market dynamics of the Antisense And RNAi Therapeutics market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.
Request for a Sample of this report: https://www.thebusinessresearchcompany.com/sample.aspx?id=3389&type=smp
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Check out our blog: http://blog.tbrc.info/
And follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
About Us:
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. It has published over 3000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antisense And RNAi Therapeutics Market 2022 Latest Insights, Growth Rate, Future Trends And Forecast | Key Players : Alnylam Pharmaceuticals, Benitec Biopharma Ltd., Gene Signal, GlaxoSmithKline Plc here
News-ID: 2656403 • Views: …
More Releases from The Business research company
Competitive Analysis: Leading Companies and New Entrants in the Wire Arc Additiv …
The wire arc additive manufacturing cell market is rapidly gaining traction as industries increasingly embrace advanced metal 3D printing technologies. With significant investments and technological breakthroughs, this sector is set to experience remarkable growth, transforming manufacturing processes across multiple fields. Let's explore the market's size, influential players, key trends, and segmentation to understand its future trajectory.
Projected Expansion of the Wire Arc Additive Manufacturing Cell Market
The wire arc additive manufacturing cell…
Future Perspectives: Key Trends Shaping the Viscosupplementation Treatment for A …
The viscosupplementation treatment for arthritis market is on the verge of significant expansion, driven by advances in medical technology and a growing demand for effective arthritis therapies. With increasing awareness around early intervention and new treatment options, this sector is poised for rapid development over the coming years. Let's explore the market size, key players, emerging trends, and segment-wise forecasts that define this growing industry.
Projected Market Growth and Size of…
Segmentation, Major Trends, and Competitive Overview of the Viral Vector Develop …
The viral vector development service market is set to experience substantial growth in the coming years, driven by technological progress and increasing demand from various sectors. As gene therapies and advanced treatments gain prominence, the need for efficient viral vector production and development is becoming more critical. Let's explore the market size projections, key players, emerging trends, and the segment structure shaping this industry's future.
Projected Expansion and Market Size of…
Competitive Landscape: Leading Companies and New Entrants in the Transient Elast …
The transient elastography market is poised for substantial expansion as advancements in healthcare diagnostics continue to evolve. Increasing emphasis on non-invasive techniques and early disease detection is driving widespread adoption, setting the stage for strong market growth in the coming years. Let's explore the current market valuation, leading players, emerging innovations, and key segments shaping this industry.
Projected Market Value and Growth of the Transient Elastography Market
The transient elastography market is…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
